HCW Biologics Inc. (HCWB)

HCW Biologics Revenue

HCW Biologics had revenue of $1.16M in the twelve months ending March 31, 2024, with 43.63% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $614.75K with 4,805.03% year-over-year growth. In the year 2023, HCW Biologics had annual revenue of $560.36K, a decrease of -78.33%.

• Revenue (ttm): $1.16M
• Revenue Growth: +43.63%
• P/S Ratio: 36.11
• Revenue / Employee: $25,835
• Employees: 45
• Market Cap: 41.98M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	560.36K	-2.03M	-78.33%
Dec 31, 2022	2.59M	-	-
Dec 31, 2021	0	-	-
Dec 31, 2020	4.10M	-	-
Dec 31, 2019	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.